Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients.

Grace Juyun KimSoo Youn LeeJi Hye ParkBrian Y RyuGrace Juyun Kim

Published in: Drug safety (2017)

This study quantified the number of South Korean patients predicted to have serious ADEs and demonstrated the need for preemptive genotyping to assist safer drug therapy in South Korea.

Keyphrases

end stage renal disease
adverse drug
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
emergency department
gene expression
high throughput
patient reported outcomes
cell therapy
single cell
genetic diversity